Emerald Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-357
| Closed | -$375K | – | 267 |
|
|
2024
Q3 | $375K | Hold |
357
| – | – | 0.01% | 191 |
|
|
2024
Q2 | $375K | Sell |
357
-202
| -36% | -$212K | 0.02% | 185 |
|
|
2024
Q1 | $538K | Sell |
559
-53
| -9% | -$51K | 0.02% | 175 |
|
|
2023
Q4 | $538K | Sell |
612
-65
| -10% | -$57.1K | 0.02% | 173 |
|
|
2023
Q3 | $557K | Buy |
677
+272
| +67% | +$224K | 0.03% | 165 |
|
|
2023
Q2 | $291K | Buy |
+405
| New | +$291K | 0.01% | 193 |
|
|
2020
Q4 | – | Sell |
-557
| Closed | -$312K | – | 337 |
|
|
2020
Q3 | $312K | Buy |
+557
| New | +$312K | 0.01% | 206 |
|
|
2013
Q3 | – | Sell |
-4,368
| Closed | -$982K | – | 355 |
|
|
2013
Q2 | $982K | Buy |
+4,368
| New | +$982K | 0.06% | 237 |
|